Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 07 Oct 2026 for TriSalus Life Sciences, Inc., €1,235. Read the official filing
Filing timeline
BuySaleJennifer Stevens
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Jennifer Stevens: trading record in brief
Jennifer Stevens appears in our data through filings on TriSalus Life Sciences, Inc. shares, published by SEC (Form 4). We count 7 filings; the first trade dates from 12 February 2024 and the latest from 5 October 2026.
Every open-market trade on record is a sale: 2 sales worth €5,517. Outside the open market, there are 5 share grants. 2026 to date brings no purchases and 2 sales.
On 7 October 2026 came the latest disclosure, an open-market sale for €1,235 in TriSalus Life Sciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jennifer Stevens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
316 shares@ US$4.39Common StockSEC:0001628280-26-065324:0
1,204 shares@ US$4.133.2% of flowCommon StockSEC:0001628280-26-020187:0
50,000 shares0Common StockSEC:0001982621-25-000009:0
28,455 shares@ US$5.1896.8% of flowCommon StockSEC:0001826667-25-000053:0
14,481 shares0Common StockSEC:0001415889-25-004687:0
10,625 shares0Common StockSEC:0001415889-25-002283:0
14,752 shares0Common StockSEC:0001415889-24-003811:0
7 of 7 declarations
